GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Total Stockholders Equity

ZYUS Life Sciences (TSXV:ZYUS) Total Stockholders Equity : C$20.07 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences Total Stockholders Equity?

ZYUS Life Sciences's Total Stockholders Equity for the quarter that ended in Mar. 2024 was C$20.07 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. ZYUS Life Sciences's Book Value per Share for the quarter that ended in Mar. 2024 was C$0.28. The ratio of a company's debt over equity can be used to measure how leveraged this company is. ZYUS Life Sciences's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.49.

ZYUS Life Sciences Total Stockholders Equity Historical Data

The historical data trend for ZYUS Life Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences Total Stockholders Equity Chart

ZYUS Life Sciences Annual Data
Trend Dec21 Dec22 Dec23
Total Stockholders Equity
- 4.74 23.11

ZYUS Life Sciences Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 50.97 46.73 23.11 20.07

ZYUS Life Sciences  (TSXV:ZYUS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

ZYUS Life Sciences's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(20.071-0)/70.8474
=0.28

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

ZYUS Life Sciences's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(6.565 + 3.297) / 20.071
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ZYUS Life Sciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of ZYUS Life Sciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

ZYUS Life Sciences (TSXV:ZYUS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Total Stockholders Equity
Comparable Companies
TSXV:DB XCNQ:HUGE TSX:CWEB XCNQ:GRIN TSX:MDP TSX:CRDL XCNQ:CXXI XCNQ:MMEN TSX:AVNT XCNQ:ACRG.A.U ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
ZLSCF:USA
Address
407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
Website
https://www.zyus.com
ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.
Executives
John Michael Hyshka Senior Officer

ZYUS Life Sciences (TSXV:ZYUS) Headlines

No Headlines